Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 132

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 132
---
                                         51 |     |             |                                           98 |     |      |                      151 |     |      |   - |
|                                |     |           |                                        331 |     |             |                                        1,162 |     |      |                      846 |     |      | 324 |

| b. | General                      
 and administrative expenses: |

|                             |     | Successor Unaudited 
 2024                | For the period commencing July 24, 
                            through 
                      September 30, |     | Predecessor audited 
 2024                | For the period commencing January 1, 
                              through 
                             July 23, |     | 2023 | Year ended  December 31, |     | 2022 |     |
|:----------------------------|:----|:--------------------|-----------------------------------:|:----|:--------------------|-------------------------------------:|:----|:-----|-------------------------:|:----|:-----|----:|
| Professional services       |     |                     |                                 40 |     |                     |                                  131 |     |      |                      148 |     |      | 111 |
| Rent and office maintenance |     |                     |                                 12 |     |                     |                                   64 |     |      |                        1 |     |      |   1 |
| Payrol expenses             |     |                     |                                 97 |     |                     |                                    - |     |      |                        - |     |      |   - |
| Share based payment         |     |                     |                                280 |     |                     |                                    - |     |      |                        - |     |      |   - |
| Others                      |     |                     |                                 35 |     |                     |                                   62 |     |      |                        7 |     |      |   - |
|                             |     |                     |                                464 |     |                     |                                  257 |     |      |                      156 |     |      | 112 |

<div align='center'>F-26</div>

REVIUM RX.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

NOTE 13 – RELATED PARTIES

As of September 30, 2024, July 23, 2024, December 31, 2023, and 2022, the balance of trade